NCT02570282View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

July 31, 2017

Conditions
Sexual Arousal Disorder
Interventions
DRUG

Placebo

Approximately 50% of the cream is to be applied externally to the clitoris and labia minora and approximately 50% is to be applied intravaginally.

DRUG

SST-6007

SST-6007 is a white to off-white cream containing 5% (w/w) sildenafil citrate

Trial Locations (1)

78712

The Sexual Psychophysiology Laboratory, Austin

All Listed Sponsors
lead

Strategic Science & Technologies, LLC

INDUSTRY

NCT02570282 - Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder | Biotech Hunter | Biotech Hunter